Des Moines, Iowa
April 29, 2003
Phytodyne, Inc.
announced that it has reached an agreement with Loyola
University of Chicago to license worldwide rights to a plant
retrovirus for use in developing gene modification tools for
plants. The retrovirus was discovered by Loyola biology
professor Howard M. Laten.
"Plant retroviruses are natural genetic engineers," said Laten.
"As part of their infectious cycle, they splice their DNA into
the chromosomes of organisms they co-exist with. What's exciting
is that this characteristic should make it relatively easy to
get a new gene into plant seeds. Phytodyne's technology will use
these retroviruses to modify plant genes and create new crop
varieties."
SIRE-1, as the retrovirus is called in the
scientific community, is the second of only two plant
retroviruses known to exist. Phytodyne already holds a license
to the other such retrovirus, discovered at
Iowa
State University by Professor Daniel Voytas and David Wright,
the co-founders of Phytodyne.
"The
SIRE-1 license will significantly accelerate the development of
our gene modification tools," said Jon Leafstedt, chief
operating officer of Phytodyne. "It strengthens our global
leadership position in developing plant retroviruses as gene
modification tools and broadens our intellectual property
portfolio."
Phytodyne is utilizing these plant retroviruses to develop their
proprietary
RetroGene gene transformation system, Leafstedt said. Research indicates
this technology will provide seed and plant biotechnology
companies a more effective, efficient, and less costly method of
gene transformation applicable to a wider range of crop species
than traditional transformation methods.
In
December, the US Patent and Trademark Office approved the patent
application for the
Iowa
State plant retrovirus. US and international patent applications
for
SIRE-1
are pending.
Phytodyne is developing plant genome modification technologies
that accelerate the creation of transgenic plant varieties by
leading biotechnology companies for agricultural, pharmaceutical
and industrial use. |